Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Transplantation. 2019 Aug;103(8):1700–1704. doi: 10.1097/TP.0000000000002563

TABLE 1.

Characteristics of adult KT candidates by classification of binary state frailty transitions (N = 569)a

Factor Stable nonfrail
(n = 424)
Nonfrail to frail
(n = 51)
Frail to nonfrail
(n = 54)
Stable frail
(n = 40)
P
Age, mean (SD) 50.8 (14.0) 54.9 (12.4) 54.5 (14.5) 54.5 (14.0) 0.04
BMI, mean (SD) 28.2 (5.4) 27.8 (5.7) 29.9 (5.8) 29.4 (7.1) 0.08
Male 60.4 54.9 74.1 55.0 0.15
Race 0.53
 White/Caucasian 58.5 45.1 46.3 47.5
 Black/African American 35.1 51.0 48.1 52.5
 Other 6.4 3.9 5.6 0.0
Charlson Comorbidity Index, median (IQR)b 1.0 (0.0–2.0) 1.0 (0.0–3.0) 2.5 (0.0–4.0) 2.0 (1.0–4.0) <0.001
Diabetes 25.5 41.2 42.6 52.5 <0.001
Cancer 1.7 0.0 0,0 5.0 0.19
Lung disease 6.1 3.9 13.0 10.0 0.19
CVD 17.3 19.6 22.2 30.0 0.22
HIV 2.1 3.9 3.7 0.0 0.56
Rheumatological disease 7.0 15.2 5.7 8.6 0.23
Cause of ESRD 0.01
 Glomerular 25.0 31.4 24.1 22.5
 Diabetes 13.7 11.8 29.6 30.0
 Hypertension 30.4 33.3 37.0 27.5
 Cystic 11.8 5.9 3.7 5.0
 Other 19.1 17.6 5.6 15.0
Y on dialysis, median (IQR) 2.0 (0.0–4.4) 2.4 (0.0–5.2) 1.3 (0.4–2.6) 2.5 (1.0–4.2) 0.36
Type of dialysis 0.06
 Hemodialysis 55.6 56.0 66.7 77.5
 Peritoneal dialysis 15.2 10.0 16.7 7.5
 Not on dialysis 29.2 34.0 16.7 15.0
Y between evaluation and KT, median (IQR) 1.1 (0.5–1.9) 1.1 (0.7–2.2) 1.1 (0.6–1.7) 0.9 (0.5–2.0) 0.81
a

Percentages are presented unless otherwise stated. Bold indicates values that are statistically significant at a cutoff of P < 0.05.

b

Charlson Comorbidity Index adapted for patients with ESRD.23,24

BMI, body mass index; CVD, cardiovascular disease; ESRD, end-stage renal disease; IQR, interquartile range; KT, kidney transplantation.